Primary Record
Saliphenylhalamide
- In stock
- 3,797 g
- Purity
- 99.7 %
- CAS
- 398478-65-4
Compound Identifiers & Properties
- CAS
- 398478-65-4
- PubChem CID
- 11271117
- SMILES
- C[C@H]1C/C=C/CC2=C(C(=CC=C2)O)C(=O)O[C@H](C[C@H]1O)C/C=C/NC(=O)C#CC3=CC=CC=C3
- Canonical SMILES
- C[C@H]1C/C=C/Cc2cccc(O)c2C(=O)O[C@@H](C/C=C/NC(=O)C#Cc2ccccc2)C[C@H]1O
Names & Synonyms
- Saliphenylhalamide
- SaliPhe
- RefChem:180988
- D0K1UF
- Saliphenylhalamide (cancer)
- CHEMBL457538
- SCHEMBL31538093
- RTA-203
- GLXC-25513
- Saliphenylhalamide (cancer), Reata
- V-ATPase inhibitor (cancer), Reata
- CID11271117
- CID 11271117
- Vacuolar H+-ATPase inhibitors (anticancer), Reata
- N-[(E)-3-[(4S,6R,7S,9E)-6,16-dihydroxy-7-methyl-2-oxo-3-oxabicyclo[10.4.0]hexadeca-1(12),9,13,15-tetraen-4-yl]prop-1-enyl]-3-phenylprop-2-ynamide
- 398478-65-4
- N-((E)-3-((3S,5R,6S,E)-5,14-Dihydroxy-6-methyl-1-oxo-3,4,5,6,7,10-hexahydro-1H-benzo[c][1]oxacyclododecin-3-yl)prop-1-en-1-yl)-3-phenylpropiolamide